Literature DB >> 10499553

Rat TRH receptor type 2 exhibits higher basal signaling activity than TRH receptor type 1.

W Wang1, M C Gershengorn.   

Abstract

Two types of rat TRH receptor (TRH-R1 and TRH-R2) have been identified and shown previously to exhibit similar binding and stimulated signaling activity via the phosphoinositide-calcium transduction pathway. Since mouse TRH-R1 exhibits basal (or constitutive or ligand-independent) signaling activity, we compared basal signaling by TRH-R1 and TRH-R2. Basal signaling was measured as receptor-mediated reporter gene induction via different transcription factors. We found that TRH-R2 exhibited higher basal signaling activity than TRH-R1 via pathways mediated by transcription factors AP-1, Elk-1 and CREB. Furthermore, CREB-mediated transcription was directly dependent on the level of TRH-R2 expression and was inhibited by midazolam, a specific inverse agonist of basal TRH-R signaling. Since TRH-R1 and TRH-R2 exhibit distinct anatomic distributions in the rat, it is possible that TRH ligand-independent signaling is more important in tissues/cells in which TRH-R2 is expressed and less important in tissues in which TRH-R1 is found.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499553     DOI: 10.1210/endo.140.10.7159

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Persistent signaling by thyrotropin-releasing hormone receptors correlates with G-protein and receptor levels.

Authors:  Alisa Boutin; Michael D Allen; Susanne Neumann; Marvin C Gershengorn
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

2.  Constitutively active thyrotropin and thyrotropin-releasing hormone receptors and their inverse agonists.

Authors:  Susanne Neumann; Bruce M Raaka; Marvin C Gershengorn
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

3.  Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice.

Authors:  Chhuttan L Meena; Shubdha Ingole; Satyendra Rajpoot; Avinash Thakur; Prajwal P Nandeker; Abhay T Sangamwar; Shyam S Sharma; Rahul Jain
Journal:  RSC Adv       Date:  2015-06-23       Impact factor: 3.361

4.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

Review 5.  Thyrotropin-releasing hormone (TRH) in the cerebellum.

Authors:  Nobuyuki Shibusawa; Koshi Hashimoto; Masanobu Yamada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 6.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

Review 7.  Biochemical and physiological insights into TRH receptor-mediated signaling.

Authors:  Radka Trubacova; Zdenka Drastichova; Jiri Novotny
Journal:  Front Cell Dev Biol       Date:  2022-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.